Licensed pct/ekg/cna
SB
SanaGen B.V.
The startup develops gene therapies that target rare genetic disorders, specifically focusing on providing life-long cures for patients with rare bleeding disorders. By utilizing advanced gene editing techniques, the company aims to make these therapies both effective and affordable for those in need.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$350KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops gene therapies that target rare genetic disorders, specifically focusing on providing life-long cures for patients with rare bleeding disorders. By utilizing advanced gene editing techniques, the company aims to make these therapies both effective and affordable for those in need.